We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
AUTHORIZED GENERIC ENTRY PRIOR TO PATENT EXPIRY: REASSESSING INCENTIVES FOR INDEPENDENT GENERIC ENTRY.
- Authors
Appelt, Silvia
- Abstract
Originators seek to mitigate the loss of monopoly power by authorizing generic entry prior to patent expiry. Off-patent competition may be adversely affected if authorized generic entry substantially lowers the attractiveness of subsequent generic entry. This study assesses the impact of authorized generic entry on independent generic entry in recent cases of patent expiry in Germany. The results of a recursive bivariate probit regression, accounting for the endogeneity of authorized generic entry, show that authorized generic entry has no significant effect on the likelihood of generic entry. Business scope expansion and rent-seeking motives drive authorized generic entry decisions.
- Subjects
GERMANY; GENERIC drugs; MARKET entry; PATENT expiration; PHARMACEUTICAL industry; BIVARIATE analysis; REGRESSION analysis
- Publication
Review of Economics & Statistics, 2015, Vol 97, Issue 3, p654
- ISSN
0034-6535
- Publication type
Article
- DOI
10.1162/REST_a_00488